GMO U.S. Value ETF (NYSEARCA:GMOV) Short Interest Down 90.1% in August

Posted by Amy Steele on Aug 25th, 2026

GMO U.S. Value ETF (NYSEARCA:GMOV – Get Free Report) was the target of a large decline in short interest in the month of August. As of August 14th, there was short interest totaling 509 shares, a decline of 90.1% from the July 30th total of 5,166 shares. Currently, 0.0% of the company’s shares are short sold. Based on an average trading volume of 10,463 shares, the short-interest ratio is currently 0.0 days.

Hedge Funds Weigh In On GMO U.S. Value ETF

Several hedge funds have recently made changes to their positions in GMOV. Fifth Third Bancorp purchased a new position in shares of GMO U.S. Value ETF during the first quarter worth approximately $84,000. Pathway Financial Advisors LLC acquired a new stake in shares of GMO U.S. Value ETF during the second quarter worth about $246,000. Kestra Private Wealth Services LLC acquired a new position in GMO U.S. Value ETF in the 1st quarter valued at about $333,000. Aspen Investment Management Inc acquired a new stake in GMO U.S. Value ETF during the 4th quarter worth approximately $333,000. Finally, RPS Advisory Solutions LLC purchased a new position in shares of GMO U.S. Value ETF in the 4th quarter valued at approximately $484,000.

GMO U.S. Value ETF Stock Performance

Shares of GMO U.S. Value ETF stock remained flat at $32.77 during trading hours on Tuesday. The stock had a trading volume of 4,131 shares, compared to its average volume of 16,090. GMO U.S. Value ETF has a 1-year low of $25.66 and a 1-year high of $32.82. The firm has a 50-day moving average of $31.18 and a two-hundred day moving average of $29.89. The company has a market capitalization of $104.86 million, a price-to-earnings ratio of 12.08 and a beta of 0.62.

GMO U.S. Value ETF Company Profile

(Get Free Report)

The GMO US Value ETF (GMOV) is an exchange-traded fund that mostly invests in total market equity. The fund is actively managed, investing primarily in US equity securities. The fund seeks to identify undervalued US stocks using proprietary quantitative methods, capitalizing on perceived market dislocations GMOV was launched on Oct 28, 2024 and is issued by GMO.